ALMOND PHARMA LTDActive

Company number 06830591Private limited companyIncorporated 2009
⚠ Confirmation statement overdue. It was due on 24 Sep 2026.

Key figures

£853+85,200.0%
Net assets 2024/25
-15.6%
Average annual change 2019/20–2024/25
0100 k200 k300 k400 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ALMOND PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets71,331137,837389,833—2,847
Total liabilities21,50075,43147,389—1,694
Net assets / total equity49,83162,406342,4441853
Average number of employees122—1

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ALMOND PHARMA LTD

Company

ALMOND PHARMA LTD is a private limited company registered with Companies House under company number 06830591. It was incorporated on 26 Feb 2009. Its status is active. The registered office is in London (EC1V). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), other service activities n.e.c. (96090).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files micro-entity accounts. Net assets were £853, up 85,200% on the previous year. Total assets were £2,847 and total liabilities £1,694. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 24 Sep 2026.